Smith Hunter C

Chief Financial Officer

Smith Hunter C has filed 7 SEC Form 4 filings (31 transaction rows) across 1 company, with disclosures dating back to 2026. 7 of those filings fall inside the rolling window. Most recent filing: Sep 1, 2026.

On the most recent filing, Smith Hunter C is listed as Chief Financial Officer at RHYTHM PHARMACEUTICALS, INC. Inside the rolling window, Smith Hunter C reported no open-market purchases and 8 open-market sales totaling $8.8M in RYTM. The largest disclosed transaction in the window is a sale of 62,774 RYTM shares on Aug 31, 2026, worth $6.6M.

Companies traded

Other insiders at RYTM

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$8.8M

reported sales (SEC code S)

Companies

1

in the rolling window

Source
RYTMSale$6.6MSep 1SEC ↗
RYTMSale$362KFeb 19SEC ↗
RYTMSale$444KFeb 19SEC ↗
RYTMSale$279KFeb 12SEC ↗
RYTMSale$273KFeb 12SEC ↗
RYTMSale$156KFeb 12SEC ↗
RYTMSale$344KFeb 6SEC ↗
RYTMSale$359KFeb 6SEC ↗
Showing 1–8 of 8
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Smith Hunter C made?

Smith Hunter C has filed 7 SEC Form 4 filings (31 transaction rows) across 1 company since 2026.

Which companies does Smith Hunter C trade?

Smith Hunter C has filed SEC Form 4 disclosures for 1 company, including RYTM.

When was Smith Hunter C's most recent SEC Form 4 filing?

Smith Hunter C's most recent SEC Form 4 filing on Tracefour is dated Sep 1, 2026.

What is Smith Hunter C's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Smith Hunter C is listed as Chief Financial Officer.

What is Smith Hunter C's total buy and sell value in the current window?

Inside the rolling retention window, Smith Hunter C bought $0 and sold $8.8M based on SEC Form 4 filings.

What was Smith Hunter C's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 62,774 RYTM shares on 2026-08-31, worth $6.6M, per SEC Form 4 filings.